Original Article

Pediatric Surgery International

, Volume 27, Issue 6, pp 595-598

First online:

Preliminary results of VATS thymectomy for pediatric myasthenia gravis

  • Ketan ParikhAffiliated withTara Neo-Surg Hospital Email author 
  • , Amrish VaidyaAffiliated withTara Neo-Surg Hospital
  • , Rajesh JainAffiliated withTara Neo-Surg Hospital

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Myasthenia gravis (MG) is a debilitating disease which necessitates long-term medical therapy. If left untreated, it can have a high mortality rate. The commonest variety in children, the autoimmune variety, often requires recourse to immunomodulation including prolonged usage of high-dose steroids. Thymectomy has not been a popular option among treating clinicians. There is evidence to suggest that if thymectomy is performed early in the disease, it has a high success rate in reducing the doses of the oral steroid medication and also in inducing remission of the disease. We have performed video-assisted thoracoscopic surgery (VATS) thymectomy in four patients with the autoimmune variety of MG. In this study, we have had a fair and comparable success rate as with the other adult series. On the basis of this preliminary study, we recommend that the option of VATS thymectomy should be offered to select patients of MG.


Myasthenia gravis VATS thymectomy